# Fibroblast Activating Protein Inhibitor PET Imaging in Lupus Nephritis

> **NCT05845151** · NA · UNKNOWN · sponsor: **Ruijin Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DIAGNOSTIC_TEST:** 68Ga-FAPI-04 PET

## Key facts

- **NCT ID:** NCT05845151
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-04-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05845151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05845151, "Fibroblast Activating Protein Inhibitor PET Imaging in Lupus Nephritis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05845151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*